Answer from: Radiation Oncologist at Academic Institution
There are several factors when evaluating patients with low/intermediate grade DCIS and the role of RT:
Estrogen negative. While rare, I almost always recommend RT.
Willingness to take endocrine therapy. More and more patients are concerned about taking endocrine therapy and I discuss RT in these ...
Comments
Radiation Oncologist at Lake Huron Medical Center Agree with Dr. @Shah regarding the discussion. A f...
Radiation Oncologist at East Alabama Medical Center How do you decide on treatment in patients with cl...
Radiation Oncologist at Cleveland Clinic If negative using no tumor on ink, I am comfortabl...
Radiation Oncologist at East Alabama Medical Center Do you mean the studies used to validate DCISionRT...
Radiation Oncologist at Cleveland Clinic Correct. With elevated risk, I use PBI. However, t...
Radiation Oncologist at East Alabama Medical Center Thank you
Radiation Oncologist at Mon Health When should we request a DCISionRT score?
Answer from: Radiation Oncologist at Academic Institution
I find that most patients can understand the concept of local recurrence risk of “1% per year of follow-up from diagnosis” without radiation. I usually present this information first. I then add that radiation had a significant impact on that local recurrence, with the 10-year rate of fa...
Answer from: Radiation Oncologist at Academic Institution
Our guidance and approach to DCIS at MSKCC is a joint guidance developed by rad onc and surgery. We developed this to try to make our approach uniform across the network. Notably, we acknowledge that outside of the absolute indications, there is a lot of unstructured decision-making based on patient...
Comments
Radiation Oncologist Thank you for this excellent summary.
Answer from: Radiation Oncologist at Academic Institution
We typically start this discussion with a general review of the pathophysiology and natural history of DCIS. We explain that radiation has not been shown in a prospective randomized trial to impact overall survival; as such, patient preference is paramount to decision-making. Based on the low-risk c...
Comments
Radiation Oncologist at Cleveland Clinic Very well stated. I will note that we are increasi...
Answer from: Radiation Oncologist at Academic Institution
For almost all patients, I explain that there is a local control benefit (2/3 reduction based on RTOG 9804, etc., which ends up being ~10% absolute reduction for most) but probably no survival benefit. My strength of recommendation would depend on age, size, margin, etc. but I always tell patients t...
Comments
Radiation Oncologist at Cleveland Clinic Agreed. For 5 fx, do you do offer off protocol per...
Radiation Oncologist at USC Keck School of Medicine Yes, I do. However, I prefer to get them on protoc...
Answer from: Radiation Oncologist at Community Practice
I plead stupidity.
As several of you cite data that many recurrences continue in years 10-15 after treatment and well beyond year 15, how can you accept APBI trials or those with hypofractionation, none of which have reached the minimum follow-up that surgeons demanded in the 1980s for accepting lu...
Comments
Radiation Oncologist at Cleveland Clinic I think the comparison is not exactly apples to ap...
Agree with Dr. @Shah regarding the discussion. A f...
How do you decide on treatment in patients with cl...
If negative using no tumor on ink, I am comfortabl...
Do you mean the studies used to validate DCISionRT...
Correct. With elevated risk, I use PBI. However, t...
Thank you
When should we request a DCISionRT score?